BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor (World)
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 11/26/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
uniQure To Host Investor Day In New York City 11/21/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS 11/17/2014
Forward Pharma (FWP) Announces Closing Of Partial Exercise Of Over-Allotment Option 11/17/2014
Actavis (ACT) Successfully Completes Durata Therapeutics, Inc.  (DRTX) Tender Offer 11/17/2014
ISI: Merck & Co. (MRK)’s Zetia News The Rising Tide To Lift All LDL Boats 11/17/2014
If Investors Like Merck & Co. (MRK)'s Zetia Results, They Will Love Esperion Therapeutics, Inc. (ESPR)’s, Says Citi 11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014
Patent Fight Between Amgen (AMGN) And Sanofi (SAN.PA)/Regeneron (REGN) Getting Murkier, Says Analyst 11/14/2014
With Promising New Gout Treatment In Its Pipeline, 2015 Will Be Big Year For CymaBay Therapeutics 11/14/2014
Analyst: Amgen (AMGN)’s Psoriasis Drug Is Superior To Stelara And Sales Will Reflect That 11/13/2014
Roche (RHHBY) Announces Early Tender Results Of Its Debt Tender Offer 11/13/2014
Regeneron (REGN), Sanofi (SAN.PA) Asthma Drug A Potential Blockbuster For Allergies, Says Analyst 11/12/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Citi: Esperion Therapeutics, Inc. (ESPR) Will See Cancer Drug Data By End Of Year 11/11/2014
Gilead Sciences, Inc. (GILD) Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst 11/11/2014
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014
Analyst: Celgene (CELG)’s Drug Pipeline Will Be The Gift That Keeps On Giving 11/10/2014
GENFIT Corp. (ALGFT) To Participate In Three Upcoming Investor Conferences 11/7/2014
TherapeuticsMD, Inc.  (TXMD) Looking At Lower Cash Burn, Higher Upside From Promising HRT Therapies: Cowen 11/7/2014
Bristol-Myers Squibb Company (BMY), Merck & Co. (MRK) Competing Hodgkin’s Drugs Look Comparable, Says Analyst 11/7/2014
Sangui BioTech International Inc. (SGBI) Officially Approved As Trading On OTCQB 11/6/2014
Meda AB (MEDA-A.ST) Extraordinary General Meeting Bulletin 11/6/2014
Pharmacyclics, Inc. (PCYC), AstraZeneca PLC (AZN) Partnership Holds Tumor Promise: Citi 11/6/2014
Galmed Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 7, 2014 In New York City 11/5/2014
Karolinska Development AB Secures Funding From CP Group, A Leading Asian Life Science Investor, And Initiates Preparation For A Convertible Bond Issue 11/5/2014
NeuroDerm Announces Launch Of Initial Public Offering 11/4/2014
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014
Change In The Number Of Shares And Votes In Meda AB (MEDA-A.ST) 10/31/2014
AbbVie (ABBV) Might Go Shopping Again Despite Shire Breakup, Say Company Execs 10/31/2014
Citi: Gilead Sciences, Inc. (GILD) Sees Blockbuster First Weeks Of Harvoni Launch 10/31/2014
Novo Nordisk A/S (NVO) Commits $130 Million In Diabetes Research In Denmark 10/31/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option 10/30/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears" 10/30/2014
Roche Holdings, Inc. Announces Debt Tender Offer 10/30/2014
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO 10/29/2014
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi 10/29/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 10/29/2014
NeuroVive Pharmaceutical AB: Annual General Meeting 2015 And Information About Members Appointed To The Nomination Committee 10/29/2014
Merck & Co. (MRK) Execs “Downplaying” Gilead Sciences, Inc. (GILD)'s Harvoni Competitor, Says Analyst 10/28/2014
Nordic Nanovector – Registered Share Capital Increase 10/28/2014
Amgen (AMGN) Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs 10/28/2014
Citi: Sarepta Therapeutics (SRPT) Will See Competition, Concern Over FDA Delay 10/27/2014
Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P 10/24/2014
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst 10/24/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen 10/24/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014
Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan 10/23/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier 10/23/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts 10/22/2014
Ablynx (ABLYF) Announces Warrant Exercise 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Nine-Month Figures For 2014: Sartorius Grows In Order Intake, Sales Revenue And Earnings 10/21/2014
Tianyin Pharmaceutical Co, Inc. Received Notices Of Non-Compliance From NYSE MKT 10/21/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt 10/21/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts 10/21/2014
DBV Technologies Announces Proposed Global Offering 10/20/2014
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment 10/20/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014
TiGenix Publishes Transparency Notification Pursuant To Article 14 Of The Law Of May 2, 2007 10/17/2014
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000 10/16/2014
Tianyin Pharmaceutical Co, Inc. Provides Update On Filing Of Form 10-K For Fiscal Year Ended June 30, 2014 10/15/2014
Orexo AB (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2014/2015 10/15/2014
Announcement Regarding Submission Of Tender Offer For Shares In Ambit Biosciences 10/15/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma 10/15/2014
Immunodiagnostic Systems Holdings plc Trading Update 10/14/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014
Nextech Venture Invest Announces First Closing Of Oncology Fund IV 10/14/2014
Easton Pharmaceuticals (OP: EAPH) Secures Financing Commitment Towards Closing Of Its Option On Canadian Medical Marijuana Facility And Business 10/14/2014
New Irish Tax Rules Won’t Faze Biotech: Analyst 10/14/2014
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc. (GILD) 10/13/2014
Spinal Atrophy Drug From Isis Pharmaceuticals, Inc. (ISIS) Showing Promise, Says UBS 10/13/2014
DiaGenic ASA: Ex Right To Receive Subscription Rights In The Rights Issue Today, 10 October 2014 10/10/2014
PRAC Decision On Leukemia Drug Good News For Ariad Pharmaceuticals, Inc. (ARIA), Says Analyst 10/10/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi 10/9/2014
Skyepharma PLC (SKYEF) – Interim Management Statement 10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO 10/8/2014
Therapix Biosciences ADRs Begin Trading On The OTCQB® 10/7/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
Medtech Startup Embo Medical Secures €3 Million Investment 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
Piper Jaffray: Companies Should Start Stockpiling Now For Ebola 10/3/2014
JSS Medical Research Announces Equity Investment By Capital Croissance PME (CCPME) 10/2/2014
Perrigo Company (PRGO) Announces Extension Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/1/2014
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN) 9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014
GW Pharmaceuticals Research And Development Day Details 9/29/2014
China Cord Blood Corporation To Hold Annual General Meeting In Hong Kong On December 11, 2014 9/26/2014
Antisense Therapeutics Limited (ANP.AX) Release: Placement And Share Purchase Plan 9/25/2014
ProQR Therapeutics B.V. (PRQR) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/24/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
Inivata Raises £4m To Realise The Potential Of Ctdna Analysis To Improve Cancer Treatment Through Simple Blood Tests 9/23/2014
Skyepharma PLC (SKYEF) Announces Notice Of Early Repayment Of Euro CRC Facility 9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million 9/19/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
Ablynx (ABLYF) Establishes Sponsored Level I ADR Programme In The United States 9/5/2014
Horizon Discovery Group Plc: Notice Of Interim Results 9/3/2014
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Medtronic, Inc. (MDT) Announces 2014 "Global Heroes" Team 8/11/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 7/30/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
IntelGenx Corp. To Host Management Call 7/21/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Cantargia’s Share Issue Of 20 MSEK Fully Subscribed 7/9/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014
Vitrolife (VITR.ST) Release: Conference Call Interim Report 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014
TopoTarget A/S Release: Report Pursuant To The Danish Securities Trading Act, Section 28a 7/1/2014
TopoTarget A/S Release: New Articles Of Association Following Capital Increase 7/1/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Shareholders Of Warnex Inc. (CC:WNX) Approve The Amalgamation With Diagnos Inc. (ADK) 6/27/2014
Endo International plc Announces Pricing Of Private Offering Of Senior Notes 6/26/2014
Endo International plc Announces Proposed Private Offering Of Senior Notes 6/25/2014
Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares 6/25/2014
Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014
Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares 6/24/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014
Neovasc Inc. (NVC) Announces Receipt Of Final Approval To Graduate To The TSX 6/20/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue 6/20/2014
BioAlliance Pharma Has Received Pre-Approval For The Secondary Listing Of The Shares Of The Merged Company On NASDAQ OMX Copenhagen 6/20/2014
AstraZeneca PLC (AZN) Release: Director/PDMR Shareholding 6/19/2014
GW Pharmaceuticals Announces Proposed Public Offering Of ADSs 6/18/2014
China Biologic Products Announces Proposed Public Offering Of Common Stock 6/18/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/17/2014
Articles Of Association For Genmab A/S (GEN.CO) 6/16/2014
Grant Of Warrants To Genmab A/S (GEN.CO) Employees 6/13/2014
200,000 Orion Corporation A-Shares Converted Into B-Shares 6/13/2014
Actavis (ACT) Announces Receipt Of Requisite Consents And Expiration Of Consent Solicitations For Forest Laboratories, Inc. (FRX) Senior Notes 6/13/2014
Biohit B-Shares Subscribed With Stock Options I And II 2013 6/12/2014
Aurinia (ISA.TO) To Commence Trading On Toronto Stock Exchange 6/11/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 6/10/2014
Actavis (ACT) Announces Offering Of Senior Unsecured Notes 6/10/2014
Orexo AB (ORXOF) Publishes Bond Prospectus And Applies For Listing Of Its Bond Loan On NASDAQ OMX Stockholm 6/9/2014
Oriola-KD Corporation Recognizes EUR 74 Million Impairment Charge For Russian Pharmaceutical Wholesale Operating Segment 6/5/2014
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 6/5/2014
New Incentive Plans In The H. Lundbeck A/S (LUN.CO) Group 6/4/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 6/3/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/2/2014
Total Number Of Voting Rights And Share Capital In Bavarian Nordic (BAVA.CO) 6/2/2014
Total Number Of Voting Rights And Share Capital In H. Lundbeck A/S (LUN.CO) As Of 31 May 2014 6/2/2014
BioLineRx Ltd. Enters Into Share Purchase Agreement With Lincoln Park Capital 5/30/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 5/30/2014
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 5/29/2014
Report Of Transactions Of Shares And Related Securities Of Bavarian Nordic (BAVA.CO) By Persons Holding Managerial Responsibilities And/Or Persons/Companies Closely Associated With Such 5/29/2014
Bavarian Nordic (BAVA.CO) Issues New Shares In Connection With Exercise Of Warrants 5/27/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 5/27/2014
TopoTarget A/S Release: Notice To Convene Extraordinary General Meeting 5/27/2014